Hyphens Pharma International (SGX:1J5) named Irene Hsu as the company's chief commercial officer, effective Jan. 2, according to a same-day filing with the Singapore Exchange.
Hsu previously served as a vice president and general manager of Amgen, China, the filing showed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.